These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20060169)

  • 21. Cytotoxic activity against a series of human tumour cell lines of some diorganotin(iv) 1,2-ethylenediamine N,N'-diacetates, N-(2-hydroxyethyl)- and N-(carbamoylmethyl)-iminodiacetates, and ortho-aminobenzoates.
    Gielen M; Willem R
    Anticancer Res; 1992; 12(1):269-71. PubMed ID: 1567175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).
    Katsoulakou E; Tiliakos M; Papaefstathiou G; Terzis A; Raptopoulou C; Geromichalos G; Papazisis K; Papi R; Pantazaki A; Kyriakidis D; Cordopatis P; Manessi-Zoupa E
    J Inorg Biochem; 2008 Jul; 102(7):1397-405. PubMed ID: 18289688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, characterization, biological activities of dimethyltin(IV) complexes of Schiff bases with ONO-type donors.
    Oztaş NA; Yenişehirli G; Ancin N; Oztaş SG; Ozcan Y; Ide S
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jun; 72(5):929-35. PubMed ID: 19185533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, crystal structures, cytotoxicity and qualitative structure-activity relationship (QSAR) of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}di-n-butyltin(IV) complexes, (n)Bu2Sn(L)2.
    Basu Baul TS; Mizar A; Chandra AK; Song X; Eng G; Jirásko R; Holcapek M; de Vos D; Linden A
    J Inorg Biochem; 2008 Sep; 102(9):1719-30. PubMed ID: 18571240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis of the interaction of novel tributyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with an improved cytotoxic profile: synthesis, structure, biological efficacy and QSAR studies.
    Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Pellerito C; Singh P; Verma P; Duthie A; de Vos D; Verma RP; Englert U
    J Inorg Biochem; 2010 Sep; 104(9):950-66. PubMed ID: 20553814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organotin(IV) based anti-HCV drugs: synthesis, characterization and biochemical activity.
    Shah FA; Sabir S; Fatima K; Ali S; Qadri I; Rizzoli C
    Dalton Trans; 2015 Jun; 44(22):10467-78. PubMed ID: 25978123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
    Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
    J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectroscopic characterizations, structural peculiarities, molecular docking study and evaluation of biological potential of newly designed organotin(IV) carboxylates.
    Sirajuddin M; Ali S; McKee V; Akhtar N; Andleeb S; Wadood A
    J Photochem Photobiol B; 2019 Aug; 197():111516. PubMed ID: 31170508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramolecular chalcogen-tin interactions in (o-MeE-C6H4)CH2SnPh3-nCln (E = S, O; n = 0, 1, 2), characterized by X-ray diffraction and 119Sn solution and solid-state NMR.
    Munguia T; López-Cardoso M; Cervantes-Lee F; Pannell KH
    Inorg Chem; 2007 Feb; 46(4):1305-14. PubMed ID: 17249659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New organotin(IV) ascorbates: synthesis, spectral characterization, biological and potentiometric studies.
    Nath M; Jairath R; Eng G; Song X; Kumar A
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):77-86. PubMed ID: 15556424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antitumor activity of novel dibutyltin carboxylates of aminoglucosyl derivatives.
    Li W; Zhang ZW; Ren SM; Sibiril Y; Parent Massin D; Jiang T
    Chem Biol Drug Des; 2009 Jun; 73(6):682-6. PubMed ID: 19635061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Dec; 41(12):1373-84. PubMed ID: 16996655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microwave-assisted synthesis, characterization and biological activities of organotin (IV) complexes with some thio Schiff bases.
    Singh RV; Chaudhary P; Chauhan S; Swami M
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Mar; 72(2):260-8. PubMed ID: 19027354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds.
    Koch B; Baul TS; Chatterjee A
    J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, structural characterization and biological study of new organotin(IV), silver(I) and antimony(III) complexes with thioamides.
    Hadjikakou SK; Ozturk II; Xanthopoulou MN; Zachariadis PC; Zartilas S; Karkabounas S; Hadjiliadis N
    J Inorg Biochem; 2008; 102(5-6):1007-15. PubMed ID: 18279959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, structure information and biochemical activity of new floro substituted organotin(IV) carboxylates.
    Shah FA; Fatima K; Sabir S; Ali S; Qadri I; ud Din N
    J Photochem Photobiol B; 2016 Jan; 154():99-107. PubMed ID: 26708070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis characterization and biological study of diorganotin(IV) complexes of monomethyl phthalate.
    Rehman W; Baloch MK; Badshah A; Ali S
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Nov; 65(3-4):689-94. PubMed ID: 16495129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advancement towards tin-based anticancer chemotherapeutics: structural modification and computer modeling approach to drug-enzyme interactions.
    Basu Baul TS; Dutta D; de Vos D; Höpfl H; Pooja ; Singh P
    Curr Top Med Chem; 2012; 12(24):2810-26. PubMed ID: 23368104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, antimicrobial and antitumor screening of some diorganotin(IV) complexes of 2-[(9H-Purin-6-ylimino)]-phenol.
    Rehman W; Badshah A; Khan S; Tuyet le TA
    Eur J Med Chem; 2009 Oct; 44(10):3981-5. PubMed ID: 19464768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.